| ACS | Autologous conditioned serum |
| ASCs | Adipose-derived mesenchymal stem cells |
| EGF | Epidermal growth factor |
| EMA | European Medicines Agency |
| FDA | Food and Drug Administration |
| GFs | Growth factors |
| HA | Hyaluronic acid |
| hUC-MSCs | Human umbilical cord mesenchymal stem cells |
| IA | Intra-articular |
| IGF-I | Insulin-like growth factor-I |
| MSCs | Mesenchymal stem cells |
| OA | Osteoarthritis |
| PRGFs | Plasma rich in growth factors |
| PRP | Platelet rich plasma |
| RM | Regenerative medicine |
| TGF-β | Transforming growth factor-beta |
| VEGF | Vascular endothelial growth factor |
| HTO | High tibia osteotomy |